188 related articles for article (PubMed ID: 1700506)
21. The inhibition of T cell proliferative responses by crosslinking CD7 and IgM-Fc receptors.
Emara M; Sanfilippo F
Cell Immunol; 1992 Oct; 144(1):143-54. PubMed ID: 1382863
[TBL] [Abstract][Full Text] [Related]
22. CD4+CD25high regulatory cells in human peripheral blood.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
[TBL] [Abstract][Full Text] [Related]
23. Direct involvement of CD7 (gp40) in activation of TcR gamma/delta+ T cells.
Carrel S; Salvi S; Rafti F; Favrot M; Rapin C; Sekaly RP
Eur J Immunol; 1991 May; 21(5):1195-200. PubMed ID: 1709867
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of CTLA-4 among T cell subsets.
Jago CB; Yates J; Câmara NO; Lechler RI; Lombardi G
Clin Exp Immunol; 2004 Jun; 136(3):463-71. PubMed ID: 15147348
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory activity of cyclosporine is dependent on the activating signal(s) provided to T cells.
Suthanthiran M
J Pediatr; 1987 Dec; 111(6 Pt 2):1008-11. PubMed ID: 2960793
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction through crosslinking CD7 and IgM-Fc receptors that inhibits T-cell proliferation.
Emara M; Carroll RG
Hum Immunol; 1992 Jul; 34(3):181-95. PubMed ID: 1385374
[TBL] [Abstract][Full Text] [Related]
28. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
[TBL] [Abstract][Full Text] [Related]
30. CD50 and CD62L adhesion receptor expression on naive (CD45RA+) and memory (CD45RO+) T lymphocytes in the elderly.
De Martinis M; Modesti M; Profeta VF; Tullio M; Loreto MF; Ginaldi L; Quaglino D
Pathobiology; 2000; 68(6):245-50. PubMed ID: 11493756
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD45RA antibodies increase the proliferation of mouse T cells to phytohemagglutinin through the interleukin 2/interleukin 2 receptor pathway.
Marvel J; Poirier G; Lightstone E
Eur J Immunol; 1989 Nov; 19(11):2005-10. PubMed ID: 2532137
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic comparison of the three populations of human lymphocytes defined by CD45RO and CD45RA expression.
Prince HE; York J; Jensen ER
Cell Immunol; 1992 Dec; 145(2):254-62. PubMed ID: 1451178
[TBL] [Abstract][Full Text] [Related]
33. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes.
Damle NK; Doyle LV; Grosmaire LS; Ledbetter JA
J Immunol; 1988 Mar; 140(6):1753-61. PubMed ID: 2964482
[TBL] [Abstract][Full Text] [Related]
34. Tracing the expression of CD7 and other antigens during T- and myeloid-cell differentiation in the human fetal liver and thymus.
Bárcena A; Muench MO; Roncarolo MG; Spits H
Leuk Lymphoma; 1995 Mar; 17(1-2):1-11. PubMed ID: 7539656
[TBL] [Abstract][Full Text] [Related]
35. Expansion of CD4+CD7- T cells, a memory subset with preferential interleukin-4 production, after bone marrow transplantation.
Leblond V; Othman TB; Blanc C; Theodorou I; Choquet S; Sutton L; Debré P; Autran B
Transplantation; 1997 Nov; 64(10):1453-9. PubMed ID: 9392311
[TBL] [Abstract][Full Text] [Related]
36. Use of the methylxanthine derivative A802715 in transplantation immunology: I. Strong in vitro inhibitory effects on CD28-costimulated T cell activities.
Lin Y; Goebels J; Rutgeerts O; Kasran A; Van Gool S; Ceuppens J; Schönharting M; Waer M
Transplantation; 1997 Jun; 63(12):1813-8. PubMed ID: 9210510
[TBL] [Abstract][Full Text] [Related]
37. Nature of the suppressor cells mediating prolonged graft survival after administration of extracted histocompatibility antigen and cyclosporine.
Yoshimura N; Kahan BD
Transplantation; 1985 Feb; 39(2):162-8. PubMed ID: 3155879
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 2 induces the expression of CD45RO and the memory phenotype by CD45RA+ peripheral blood lymphocytes.
Roth MD
J Exp Med; 1994 Mar; 179(3):857-64. PubMed ID: 8113679
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD31 epitopes on human lymphocytes: CD31 monoclonal antibodies differentiate between naive (CD45RA+) and memory (CD45RA-) CD4-positive T cells.
Ashman LK; Aylett GW
Tissue Antigens; 1991 Nov; 38(5):208-12. PubMed ID: 1723542
[TBL] [Abstract][Full Text] [Related]
40. Long-term proliferation and survival of in vitro-activated T cells is dependent on Interleukin-2 receptor signalling but not on the high-affinity IL-2R.
Hedfors IA; Brinchmann JE
Scand J Immunol; 2003 Nov; 58(5):522-32. PubMed ID: 14629624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
